Stock TBIO TRANSLATE BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Translate Bio, Inc.

Equities

TBIO

US89374L1044

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Translate Bio, Inc.(NasdaqGS:TBIO) dropped from S&P TMI Index
CI
Translate Bio, Inc.(NasdaqGS:TBIO) dropped from S&P Global BMI Index
CI
Translate Bio, Inc.(NasdaqGS:TBIO) dropped from S&P Biotechnology Select Industry Index
CI
Translate Bio : LifeSci Index Partners
AQ
Insider Sell: Translate Bio
MT
Insider Sell: Translate Bio
MT
Insider Sell: Translate Bio
MT
Translate Bio : Sanofi Completes Translate Bio Buyout
MT
TRANSLATE BIO, INC. : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)
AQ
Translate Bio, Inc.(NasdaqGS:TBIO) dropped from NASDAQ Composite Index
CI
Translate Bio, Inc.(NasdaqGS:TBIO) dropped from NASDAQ Biotechnology Index
CI
Sanofi completed the acquisition of remaining 95.1% stake in Translate Bio, Inc. from The Baupost Group, LLC, Ronald Renaud and other shareholders.
CI
Translate Bio : Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
AQ
Translate Bio : Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
AQ
Sanofi : Bionity - Sanofi to acquire Translate Bio
AQ
Translate Bio : Announces Second Quarter 2021 Financial Results and Provides Corporate Update
AQ
Translate Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
GL
Translate Bio, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
TRANSLATE BIO : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
AstraZeneca : Analysis-Sanofi's COVID-19 vaccine setback, drug pipeline cast long shadow
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TBIO Stock
  4. News Translate Bio, Inc.